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Abstract
Target-site resistance is commonly caused by qualitative
changes in insecticide target-receptors and few studies have
implicated quantitative changes in insecticide targets in
resistance. Here we show that resistance to imidacloprid in a
selected strain of Nilaparvata lugens is associated with a
reduction in expression levels of the nicotinic acetylcholine
receptor (nAChR) subunit Nla8. Synergism bioassays of the
selected strain suggested resistance was conferred, in part, by
a target-site mechanism. Sequencing of N. lugens nAChR
subunit genes identiﬁed no mutations associated with resis-
tance, however, a decrease in mRNA and protein levels of
Nla8 was observed during selection. RNA interference knock-
down of Nla8 decreased the sensitivity of N. lugens to
imidacloprid, demonstrating that a decrease in Nla8 expres-
sion is sufﬁcient to confer resistance in vivo. Radioligand
binding assays revealed that the afﬁnity of the high-afﬁnity
imidacloprid-binding site of native nAChRs was reduced by
selection, and reducing the amount of Nla8 cRNA injected into
Xenopus oocytes signiﬁcantly decreased imidacloprid potency
on recombinant receptors. Taken together, these results
provide strong evidence that a decrease in Nla8 levels confers
resistance to imidacloprid in N. lugens, and thus provides a
rare example of target-site resistance associated with a
quantitative rather than qualitative change.
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Insecticide resistance is an ongoing constraint in insect pest
management. As early as 1946, the ﬁrst case of resistance to
the insecticide dichlorodiphenyltrichloroethane was recorded
(Barnes 1946). Since then, resistance has been described in a
huge number of different insect species, involving a wide
array of different insecticide classes (APRD, http://
www.pesticideresistance.com). For most insecticide classes,
resistance has been shown to result primarily from enhanced
detoxiﬁcation, termed metabolic resistance (Devonshire
1991; Scott 1999; Enayati et al. 2005; Li et al. 2007), or
target-site insensitivity, termed target-site resistance (Mutero
et al. 1994; Martinez-Torres et al. 1998). For target-site
resistance, one or more mutations, often at conserved
positions, have been shown to confer insensitivity. Classic
examples of this, that have now been identiﬁed in a wide
range of insect species, include a single amino acid mutation
A302S in the GABA receptor Rdl, which confers resistance
to cyclodiene insecticides (Ffrench-Constant et al. 1993),
and point mutations in the voltage-gated sodium channel,
which confer knockdown resistance to pyrethroid insecti-
cides (Williamson et al. 1996). Examples for neonicotinoid
insecticides, a globally important class of insecticides
worldwide, include the Y151S substitution identiﬁed in
two nicotinic acetylcholine receptor (nAChR) a subunits of
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an imidacloprid selected strain of the brown planthopper,
Nilaparvata lugens (Liu et al. 2005) and R81T in the
nAChR b1 subunit of peach–potato aphid, Myzus persicae,
ﬁeld strains that are highly resistant to neonicotinoids (Bass
et al. 2011a).
Beyond qualitative changes in insecticide target sites, few
reports have described quantitative changes in target proteins
associated with resistance. Exceptions are a handful of
reports associating changes in expression of nAChRs,
ryanodine receptors, and acetylcholinesterases with resis-
tance. Investigation of neonicotinoid-resistant ﬁeld popula-
tions and susceptible laboratory strains of Musca domestica
L. revealed a reduction in the expression of nAChR subunit
Mda2 in the resistant populations (Markussen and Kristensen
2010). Changes in expression of nAChR subunits have also
been described in the pea aphid, Acyrthosiphon pisum, with
larvae treated with imidacloprid, thiamethoxam, or clothian-
idin, showing increase in the expression of Apisuma10 and
Apisumb1, and decreases in the expression of Apisumb2
(Taillebois et al. 2014). The ryanodine receptor is the target-
site of the newer diamide insecticides and the mRNA level of
this receptor in resistant strains of diamondback moth
(Plutella xylostella L.) were found to be 2.9-fold that of
the susceptible strain (Yan et al. 2014), although resistant
strains also carried the G4946E mutation known to confer
high levels of resistance to diamides. In the case of
acetylcholinesterases, the gene encoding this enzyme, ace,
has been reported to be over-expressed in resistant strains of
several arthropod species when compared with susceptible
strains, in some cases as a result of gene duplication/
ampliﬁcation (Gao and Zhu 2002; Hsu et al. 2008; Pan et al.
2010; Shen et al. 2012; Edi et al. 2014; Shang et al. 2014;
Weetman et al. 2015). Although over-expressed ace genes
may also carry target-site mutations that confer resistance,
the elevated expression has in certain cases also been shown
to provide an adaptive advantage (Edi et al. 2014; Weetman
et al. 2015).
With the exception of ace, the cases detailed above have
reported a simple correlation between a change in mRNA or
protein level of an insecticide target and insecticide resis-
tance, however, ﬁrm evidence demonstrating a causative role
in resistance has been lacking. In the present study, a
decrease in the abundance of a nAChR subunit Nla8 was
observed in an imidacloprid-resistant strain of N. lugens and
several lines of evidence provided support that this alteration
is directly involved in resistance.
Materials and methods
Brown planthopper (N. lugens) strain
The original N. lugens population used in this study was collected
from a paddy ﬁeld in Nueva Ecija (Philippines) in August 2011.
Bioassay and resistance selection were performed using the rice-
stem dipping method with ﬁfth-instar nymphs (Wang et al. 2008).
In bioassays, six concentrations of imidacloprid were used to assess
the sensitivity of each generation or population and to determine
LC50 and LC75. For resistance selection, the LC75 concentration of
each parental generation was used to treat the insects of the
following generation. For synergism bioassays, 6 lg of synergists
(2 lg for each of triphenyl phosphate, diethyl maleate, and
piperonyl butoxide) in 0.08 lL acetone was delivered onto the
prothorax notum of ﬁfth-instar nymphs 1 h before exposure to
imidacloprid (Tang et al. 2010).
Assessment of mRNA and protein levels
Total RNA was extracted from three to six pools of ﬁve adult BPHs
using Trizol reagent following the manufacturer’s instruction
(Invitrogen, Carlsbad, CA, USA). The mRNA levels of the different
nAChR subunit genes were measured by qRT-PCR, using the One
Step SYBR PrimeScript RT-PCR Kit (Takara, Dalian, China). In a
previous study, ﬁve subunits (Nla1, Nla2, Nla3, Nla8, and Nlb1)
were found to constitute two binding sites for imidacloprid in
N. lugens (Li et al. 2010), so these subunits were selected for qRT-
PCR. Nla6, which is not related to imidacloprid binding, was also
selected as a negative control. For normalization, two reference
genes, b-actin and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), were validated experimentally for each generation and
treatment, with the geometric mean of the selected genes then used
for normalization according to the strategy described previously
(Vandesompele et al. 2002). The sequences for qRT-PCR primers
were included in Table S2. Protein levels for different subunits were
measured using an immunoblotting method as previously described
(Liu et al. 2005). The speciﬁc antibodies for different nAChR
subunits and reference proteins were prepared as previously reported
(Li et al. 2010). Membrane proteins were extracted from insects as
described previously (Liu et al. 2005). N. lugens (50 mg) were
homogenized in 50 mL of extraction buffer (pH 7.2, 0.32 mM
sucrose, 100 mM EDTA, and 1% proteinase inhibitor mixture I;
Sigma, St Louis, MO, USA). The homogenate was centrifuged at
1000 g for 30 min. The resultant supernatant was ﬁltered through
four layers of cheesecloth and centrifuged at 30 000 g for 60 min.
The pellet was resuspended in incubation buffer (pH 7.4, 0.05 mM
Tris, 0.12 mM NaCl, and 100 mM EDTA). Protein content was
determined by a Bio-Rad Laboratories, Hercules, CA, USA DC
protein assay using bovine serum albumin as a standard (Bradford
1976). Extracted proteins were separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotted
onto nitrocellulose membranes (Amersham Pharmacia Biotech,
Piscataway, NJ, USA). Membranes were blocked and then
incubated with 1 : 1200 dilution of speciﬁc antibody for 1 h at
room temperature (25 C). The nitrocellulose membrane was
washed thoroughly, incubated with 1 : 2000 dilution of horseradish
peroxidase-conjugated goat anti-mouse IgG solution (CWBIO,
Beijing, China), and processed, using the enhanced chemilumines-
cence detection system (Amersham Pharmacia). GAPDH
(C_NLTH5658 in BPH EST database (http://bphest.dna.af-
frc.go.jp/; Noda et al., 2008), b-tubulin (C_NLTA0757) and b-
actin (EU179846) were ﬁrst selected as reference proteins. After
evaluation of the stable expression in different generations (Fig-
ure S1), b-actin (EU179846) was ﬁnally employed as the reference
standard to normalize the protein levels between samples. The
intensity of each band was determined using Image J software (NIH,
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http://rsb.info.nih.gov/ij/). The ﬁrst band was framed with the
rectangle selection tool in Image J, and then the ‘Analyze-Gels-
Select Next Lane’ command was used to select an equal area in
other lanes. Average pixel intensity was plotted across the selection
box in each lane, with the protein band seen as a peak above the
background pixel intensity. The area under the peak was calculated.
For each protein, the band intensity (area under the peak) was
normalized to the band intensity of b-actin band in each lane
calculated by the same method.
RNA interference
RNA interference (RNAi) was performed as previously described
(Liu et al., 2010). The dsRNA for different genes was prepared
using T7 Ribomax Express RNAi System (Promega, Madison, WI,
USA). A ﬁxed volume of 50 nL, with different dsRNA concentra-
tions to obtain different dsRNA amounts, was microinjected into
insects at the conjunctive between prothorax and mesothorax.
Injected insects were placed on fresh rice seedlings to recover, and a
sample of the injected insects was randomly selected and kept at
80°C for further tests.
[3H]imidacloprid binding assays
Radioligand binding assays were performed as described previously
(Liu et al. 2005; Li et al. 2010). In a total volume of 300 mL
incubation buffer, the receptor preparation (0.2–0.3 mg protein per
assay) was incubated for 120 min at 4°C with appropriate concen-
tration of [3H]imidacloprid. Samples were assayed by ﬁltration onto
Whatman GF/B ﬁlters pre-soaked in 0.5% polyethylenimine,
followed by rapid washing with ice-cold saline buffer (pH 7.4,
20 mM Na2HPO4, 0.15 M NaCl, and 0.2% bovine serum albumin).
The ﬁlters were transferred into the scintillation vials, and the
radioactivity remaining on the ﬁlter was assayed after overnight
incubation in 3 mL of scintillation cocktail (OptiPhase Supermix;
PerkinElmer, Waltham, MA, USA) on an LS6500 Liquid Scintilla-
tion Counter (Beckman Coulter, Fullerton, CA, USA). Speciﬁc
binding was deﬁned as the difference in radioactivity in the absence
and the presence of unlabeled imidacloprid with a 1000-fold molar
excess (compared to [3H]imidacloprid concentrations used).
Electrophysiological recording
N. lugens Nla3 (AY378700), Nla8 (FJ481979), and Rattus norvegi-
cus b subunit rat b2 (L31622) were subcloned into the expression
vector pGH19 as described previously (Liu et al. 2006; Yixi et al.
2009). Subunit cRNAs were generated using the mMESSAGE
mMACHINE T7 transcription kit (ABI-Ambion, Foster, CA, USA).
Xenopus oocyte preparation and cRNA injection were performed as
described previously (Liu et al. 2006). The amount of Nla3 and rat b2
cRNAs injected into the oocyte was 50. The amount of injected cRNA
of Nla8 was varied from 50 to 10 ng. Electrophysiological recordings
on Xenopus oocytes were made using a two-electrode voltage clamp
(Multiclamp 700BAmpliﬁer; Axon Instruments, Foster, CA,USA) as
previously described (Liu et al. 2006).
Statistical analysis
Signiﬁcant differences were analyzed by one-way ANOVA with at
least three repeats. Multiple comparisons between the groups were
performed using S-N-K method. The level of signiﬁcance for results
was set at p < 0.05.
Results
Selection of imidacloprid resistance and synergist bioassays
A ﬁeld-derived strain of N. lugens from the Philippines was
selected with imidacloprid for 26 generations. Resistance
was found to develop slowly over the ﬁrst 14 generations of
selection reaching 49-fold resistance by the 14th generation
(G14) (Fig. 1). The resistance then increased sharply in the
following two generations (G15–16) before stabilizing with
only a slight increase observed in the following nine
generations (G17–26), from 426- to 448-fold. When three
commonly used insecticide synergists, triphenyl phosphate,
diethyl maleate and piperonyl butoxide, that inhibit detox-
iﬁcation enzymes were used in combination with imidaclo-
prid, much of the resistance of the selected strain was
overcome, suggesting a signiﬁcant metabolic component to
the resistance. The greatest synergistic effect was seen with
the use of piperonyl butoxide (Figure S2), suggesting
cytochrome P450s are the primary enzyme system involved
in the resistance. The characterization of this metabolic
component of the resistance was explored in a separate study.
Despite this ﬁnding, a ‘non-metabolic’ component of the
resistance remained after the use of synergists, especially in
the increase from 7- to 57-fold from G14 to G16.
Imidacloprid resistance was associated with a reduction in
Nla8 subunit mRNA and protein levels
To investigate if the imidacloprid resistance of the selected
N. lugens strain was associated with mutation of the target-
site, the cDNA sequences for ﬁve nAChR subunits, Nla1,
Nla2, Nla3, Nla8, and Nlb1, related to imidacloprid binding
were compared between the pooled individuals from G14
and G16 (Li et al. 2010). No non-synonymous mutations
associated with imidacloprid resistance were observed in any
of the subunit sequences (data not shown). To explore
Fig. 1 Imidacloprid resistance of a strain of Nilaparvata lugens under
selection with imidacloprid and the impact of co-application of three
synergists (piperonyl butoxide, triphenyl phosphate, diethyl maleate)
on resistance. Resistance is expressed as ‘Resistance Ratios’ calcu-
lated by dividing the LC50 of the selected population with the LC50 of
the unselected population.
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potential quantitative changes in the nAChR and association
with resistance, mRNA and protein levels of these ﬁve
nAChR subunits potentially involved in imidacloprid bind-
ing were analyzed by quantitative PCR and immunoblotting
in certain key generations of the imidacloprid selected strain
(G1, G14, G16, and G25). Nla6, a subunit not related to
imidacloprid binding, was also selected as a negative control.
A signiﬁcant decrease in both mRNA and protein levels was
only detected for the Nla8 subunit (Figure S3). Following
this ﬁnding, the mRNA and protein levels of Nla8 were
tested for all generations. A signiﬁcant decrease in Nla8
subunit mRNA levels was found from G14 to G16. Small,
but still signiﬁcant, changes in Nla8 mRNA levels were also
observed before G14 (Fig. 2a). Similar signiﬁcant decreases
in Nla8 protein levels were observed from G14 to G16.
Overall protein levels showed a greater reduction than
mRNA levels, falling more than 3-fold between G14 and
G16 (Fig. 2a and b). No signiﬁcant further decreases in
mRNA or protein levels were observed from G16 to G25.
RNAi knockdown of Nla8 reduces sensitivity to imidacloprid
in vivo
In order to evaluate the effects of Nla8 quantity on
imidacloprid sensitivity in vivo, Nla8 mRNA levels were
knocked down by RNAi and the consequent reduction in
Nla8 protein levels were determined. The effect of knock-
down on the imidacloprid sensitivity of injected insects was
then determined following different injection regimes. When
dsRNA of Nla8 was applied to G1 of the N. lugens strain
both Nla8 mRNA and protein levels were signiﬁcantly
reduced only after a double injection (Fig. 3). The level of
knockdown was concentration-dependent with the highest
level of knockdown observed when 50 ng dsRNA was
injected twice, with mRNA decreasing to 29% of controls.
The mortality of injected insects after exposure to 2 ng
imidacloprid per hopper (determined 4 days after dsRNA
injection when Nla8 mRNA levels were lowest) showed a
decrease to 35.9% of the controls. Similarly, mortality 8 days
(a)
(b)
Fig. 2 (a) Expression of Nla8 mRNA and
protein levels during imidacloprid selection
of a ﬁeld-collected Nilaparvata lugens strain.
Blue columns represent mRNA levels
plotted as means  SEM of at least three
repeats. Red columns represent protein
levels plotted as means  SEM of three
repeats in key generations. Green columns
represent protein levels determined by a
single test. (b) Levels of expressed Nla8
subunit proteins in several key generations
of the selected strain as assessed by
immunoblot. Different lowercase and
uppercase letters indicate signiﬁcant




Fig. 3 The quantity of Nla8 mRNA and expressed protein after
injection with dsRNA and mortality of injected insects to imidacloprid.
T1 and T2 were single injections of 25 and 50 ng dsRNA, respectively;
T3, T4, and T5 were double injections of 30, 40, and 50 ng dsRNA,
respectively. (a) Open blue columns represent Nla8 mRNA levels
4 days after dsRNA injection at the third instar. Open red columns
represent Nla8 protein levels 8 days after dsRNA injection. Mortality I,
indicated by ﬁlled blue columns, was determined 4 days after dsRNA
injection when RNAi knockdown of Nla8 mRNA was the highest.
Mortality II, indicated by ﬁlled red columns, was determined 8 days
after dsRNA injection when knockdown of Nla8 protein level was
greatest. Data are means of at least three independent exper-
iments  SEM. (b) Nla8 protein detected by immunoblot over the
same time period. Different letters above the same colour columns
indicate signiﬁcant differences among treatments.
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after dsRNA injection (when Nla8 protein level was lowest)
decreased to 22.3%. It is noteworthy that the biggest
decreases in imidacloprid mortality corresponded to the time
when Nla8 protein levels were lowest, rather than the time
when mRNA levels were lowest.
Radiolabeled imidacloprid-binding assays to native
membrane preparations of the imidacloprid selected
N. lugens strain
Previous studies on the native subunit composition of
N. lugens nAChR subtypes revealed that nAChRs containing
the Nla3/Nla8/Nlb1 subunits constitute the high-afﬁnity
binding site for imidacloprid (Li et al. 2010). To investigate
if the reduction in Nla8 mRNA and protein levels seen in the
selected strain was associated with changes in imidacloprid
binding to the nAChR, [3H]imidacloprid binding was
performed on native membrane proteins extracted from
G14 and G16 individuals of the imidacloprid selected strain.
Two imidacloprid-binding sites with different afﬁnities were
observed in G14, in which the dissociation constant (Kd
values) for the high- and low-afﬁnity binding sites were
3.18  0.43 pM and 1.78  0.19 nM, respectively
(Fig. 4a). These results are consistent with our previous
study (Liu et al. 2005) and the ﬁndings in other Hemipteran
insects, such as M. persicae and Nephotettix cincticeps (Lind
et al., 1998). Although two different afﬁnity binding sites
were also detected in G16, the Kd value (Table S1) of the
high-afﬁnity binding site was 10.8 times that of G14. A
signiﬁcant decrease in maximum binding capacity (Bmax) for
the high-afﬁnity site was also observed (Table S1). In
contrast, there were no signiﬁcant differences in imidacloprid
binding (Kd or Bmax values) to the low-afﬁnity binding sites
between G14 and G16. These results are well illustrated by
transformation of the data in the form of a Scatchard plot
(Fig. 4b).
Influence of Nla8 quantity on imidacloprid response on
recombinant receptors
Since it is difﬁcult to generate insect functional nAChRs in
heterologous expression system, a successful strategy is to
co-express insect nAChR a subunits with a vertebrate non-a
subunit, such as rat b2 (Millar 2009). Previous studies of
hybrid nAChRs expressed in Xenopus oocytes have indicated
that Nla3 and Nla8 subunits are likely co-assembled with
rb2 into one receptor (Yixi et al. 2009). In order to conﬁrm
the inﬂuence of Nla8 levels on agonist potencies on
recombinant receptors, triplet nAChRs Nla3/Nla8/rb2 with
different quantities of Nla8 subunit were generated in
Xenopus oocytes by injection of different amounts of Nla8
cRNA. When the amount of injected cRNA of Nla8 was
decreased from 50 to 30 ng, the inward currents evoked by
acetylcholine and imidacloprid were both signiﬁcantly
decreased (Fig. 5a). However, there was no signiﬁcant
difference in the potency of either agonist (EC50 values)
(Fig. 5b). Interestingly, further reducing Nla8 cRNA to
20 ng resulted in a large rightward shift in the dose–response
curve for imidacloprid (9.0-fold increase in EC50). Under this
injection regime, the maximal agonist response (Imax) for
imidacloprid on the receptors recovered to a similar level to
that of receptors when 50 ng of Nla8 had been injected. The
decrease in Nla8 cRNA injection to 20 ng caused a small but
statistically signiﬁcant rightward shift in the dose–response
curve of acetylcholine (1.8-fold increase in EC50, Figure S4).
Discussion
As outlined in the introduction, a great deal of work has been
done over the last 50 years to characterize, at the molecular
level, insecticide resistance resulting from mutations in the
insecticide target sites. In the majority of cases, rigorous
functional analyses have been carried out to deﬁnitively
prove the causal effect of these target-site alterations in
reducing or modifying insecticide binding. However, to date,
much less work has been carried out to examine the effect of
quantitative changes in insecticide target-sites on resistance,
and the few reports that have been published often describe
simple correlations with resistance, and have lacked func-
tional evidence that clearly supports a role in resistance.
In this study, we provide several lines of evidence that a
change in the mRNA and protein levels of an insecticide
(a) (b)
Fig. 4 Radioligand binding of [3H]imidaclo-
prid to Nilaparvata lugens native nAChRs
from G14 and G16 of the imidacloprid
selected strain. (a) Equilibrium saturation
binding of [3H]imidacloprid to membrane
preparation extracts of N. lugens. (b)
Scatchard plot of data presented in (a).
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target-site confers resistance. Continuous selection of a ﬁeld-
collected strain of N. lugens with imidacloprid resulted in a
substantial increase in resistance with a particularly rapid
increase observed from G14 to G16. Synergism bioassays
using inhibitors of metabolic enzymes, strongly suggested
that a considerable component of the resistance observed in
this strain was metabolic, with cytochrome P450s particu-
larly implicated. Metabolic resistance in N. lugens has been
previously well characterized with two P450s, CYP6ER1,
and CYP6AY1, thought to confer imidacloprid resistance in
ﬁeld populations worldwide (Bass et al. 2011b; Ding et al.
2013; Garrood et al. 2015). For this reason, in this study, we
focused on investigating the molecular basis of the signif-
icant non-metabolic component of resistance. Sequencing of
genes encoding nAChR subunits from imidacloprid selected
and unselected N. lugens strains failed to identify any non-
synonymous mutations associated with resistance. This
included the Y151S and R81T amino acid substitutions
described previously in neonicotinoid-resistant N. lugens and
M. persicae, respectively (Liu et al. 2005; Bass et al.
2011a).
Although no alterations in the amino acid sequence of the
imidacloprid selected strains were identiﬁed, assessment of
mRNA and protein levels of each nAChR subunit revealed a
signiﬁcant decrease in Nla8 from G14 to G16. Decreases in
Nla8 protein levels were greater than those of mRNA
expression suggesting that the changes in the selected strain
may result from transcriptional, post-transcriptional, or post-
translational regulation of Nla8. However, the mRNA level
of a gene does not always precisely correlate with its protein
level (Maier et al. 2009) and so further research is required
to conﬁrm or refute this.
To explore whether a reduction in this subunit subtype has
any inﬂuence on imidacloprid susceptibility, RNAi was used
to knockdown the Nla8 expression and the effect of this on
mortality after exposure to imidacloprid was examined. The
results clearly revealed that silencing Nla8 caused a reduc-
tion in imidacloprid sensitivity in vivo with mortality of
injected insects reducing to 22% of controls when Nla8
protein levels were lowest.
To investigate if the reduction in Nla8 was associated
with changes in the afﬁnity of imidacloprid binding to
nAChRs, we performed radiolabeled imidacloprid binding to
native membrane proteins extracted from G14 and G16
individuals of the imidacloprid selected strain. An overall
reduction in imidacloprid binding was seen to receptors of
G16 individuals when compared with those of G14
individuals and this resulted from a 10-fold reduction in
the afﬁnity of imidacloprid binding to the high-afﬁnity
imidacloprid-binding site. Interestingly, no differences were
observed in the afﬁnity of the low-afﬁnity imidacloprid-
binding site. nAChRs comprise ﬁve subunits assembled
from a diverse family of subtypes, which may associate to
form homomeric or heteromeric receptors (Sattelle 1980; Liu
et al. 2005; Millar and Denholm 2007). Recent study of
nAChR subunits in N. lugens has suggested which subunits
of the nAChR contribute to the formation the two imida-
cloprid-binding sites (Li et al. 2010). This work has shown
that the Nlb1 subunit is an absolute requirement for the
imidacloprid binding and that nAChRs containing Nla1,
Nla2, and Nlb1 constitute the lower afﬁnity site whereas
nAChRs containing Nla3, Nla8, and Nlb1 constitute the
higher afﬁnity site. Given these ﬁndings, it is particularly
interesting that only the high-afﬁnity imidacloprid-binding
site that contains Nla8 subunit, showed a reduction in
afﬁnity to imidacloprid consistent with a hypothesis that
reduced expression of Nla8 results in reduced imidacloprid
binding and hence resistance.
(a) (b)
Fig. 5 The effect of different injection amounts of Nla8 cRNA on
agonist-evoked responses of triplet recombinant nAChRs Nla3/Nla8/
rb2 expressed in Xenopus oocytes. (a) Representative responses
evoked by 1 mM acetylcholine or imidacloprid on Nla3/Nla8/rb2. (b)
Concentration–response curves for imidacloprid on Nla3/Nla8/rb2
expressed with Nla8 injection amounts of 50, 30, and 20 ng. In all
experiments the injection amount of Nla3 and rb2 cRNA was held at
50 ng. Data are the means  SEM of at least three independent
experiments (different batches of oocytes).
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To investigate this possibility further, the inﬂuence of
Nla8 levels on agonist potency of recombinant nAChRs
receptors assembled from Nla3/Nla8/rb2 was explored by
functional expression in Xenopus oocytes. When the amount
of Nla8 cRNA injected into Xenopus oocytes was reduced
from 50 to 20 ng, a signiﬁcant increase in imidacloprid
EC50 was observed, i.e. the potency of imidacloprid against
recombinant receptors was reduced. In heteromeric recep-
tors, such as native Nla3/Nla8/Nlb1 receptors in N. lugens
and recombinant Nla3/Nla8/rb2 receptors in Xenopus
oocytes, the various ratios of the different subunit subtypes
may inﬂuence the pharmacological characteristics of the
receptor and this may extend to its sensitivity to insecti-
cides. In a study of human nAChRs, altering the various
ratios of a4 and b2 subunits in a4/b2 nAChRs resulted in
the generation of two functional classes of receptors in
Xenopus oocytes (Zwart and Vijverberg 1998). When the
injected cRNA ratio of a4 : b2 was 1 : 9, the resulting
nAChRs were more sensitive to acetylcholine with an EC50
value of 1.84 lM. When the injected cRNA ratio of a4 : b2
was 9 : 1 or 1 : 1, the EC50 value was ~ 60 lM. Further
studies using metabolic labeling with [35S]methionine found
that the low-afﬁnity nAChRs had a stoichiometry of
(a4)3(b2)2 and the high-afﬁnity nAChRs (a4)2(b2)3 (Nelson
et al. 2003). In the nematode Ascaris suum, changing the
stoichiometry of the receptor reproduced two pharmacolog-
ical subtypes of nAChRs (Williamson et al. 2009). When
the ratio of Asu-unc-38 : Asu-unc-29 was 5 : 1, nicotine
was a full agonist. However, nicotine became a partial
agonist when this ratio was reversed. Taken together, these
studies demonstrate that changes in the subunit ratios can
alter the subunit composition of nAChRs and modify the
pharmacological characteristics of the receptor. In our study,
during imidacloprid selection of the resistant strain, the
greatest shift in the resistance occurred when Nla8 protein
levels decreased by more than 60%. Consistent with this
was the results of RNAi experiments where the mortality of
N. lugens exposed to imidacloprid was substantially
decreased only after a 60% reduction in Nla8 protein was
achieved. It is possible that a certain threshold of reduction
in Nla8 is required to confer resistance and this could be
explained by a change in the composition of nAChRs after
this threshold is crossed. In support of this, a 60% reduction
in the amount of Nla8 cRNA injected into Xenopus oocytes
during the generation of Nla3/Nla8/rb2 recombinant recep-
tors resulted in a large rightward shift in the dose–response
curve for imidacloprid.
In the present study, our ﬁndings provide a body of
evidences that a reduction in Nla8 results in resistance to
imidacloprid. Further work is now required to investigate
the precise genetic changes that result in the decreased
expression of Nla8 mRNA and protein levels. One possible
scenario is a cis-acting mutation in an up- or down-stream
regulatory region of the Nla8 gene that modiﬁes the
binding of a transcription factor. Alternatively, a mutation
may have occurred in a trans-acting factor that regulates the
expression. In this regard, a diverse range of proteins have
been shown to regulate the expression levels of nAChRs
including ubiquilin-1, UBXD4, and 14-3-3 protein (Jones
et al. 2010). Ubiquilin-1 was shown to directly interact
with unassembled human nAChR a subunits, and to reduce
the surface expression of a3/b2 nAChRs (Ficklin et al.
2005). UBXD4 was found to increase the surface expres-
sion of a3-containing nAChRs (Rezvani et al. 2009).
Finally 14-3-3g, as a member of the 14-3-3 proteins
family containing seven isoforms, increased the steady-state
levels of a4 subunit and a4/b2 nAChRs (Jeanclos et al.
2001).
Acknowledgments and conflict of interest
disclosure
The Nanjing Agricultural University receives support from the
National Natural Science Foundation of China (31322045,
31130045, and 31171869), Jiangsu Science for Distinguished
Young Scholars (BK20130028), and the National High Technology
Research and Development Program of China (2011AA10A207 and
2012AA101502). Rothamsted Research receives grant-aided sup-
port from the Biotechnology and Biological Sciences Research
Council of the UK. All the authors declare no conﬂict of interest.
All experiments were conducted in compliance with the ARRIVE
guidelines.
Supporting information
Additional supporting information may be found in the online
version of this article at the publisher's web-site:
Figure S1. Comparison of three reference proteins among
generations under selection. From left to right, the columns were
for the 1st (G1), 14th (G14), 15th (G15), 16th (G16) and 25th (G25)
generations.
Figure S2. The synergistic effects of three different synergists on
imidacloprid resistance levels at four key generations during
selection.
Figure S3. mRNA and protein expression levels for different
nAChR subunits from four representative generations of the selected
strain. G1m, G14m, G16m and G25m show mRNA levels for each
tested subunits in the 1st, 14th, 16th and 25th generations, and G1p,
G14p, G16p and G25p show protein levels in these generations.
Signiﬁcant differences in mRNA and protein levels between
generations are indicated by different lowercase and uppercase
letters respectively.
Figure S4. Concentration-response curves for acetylcholine on
Nla3/Nla8/rb2 recombinant receptors expressed with 50, 30 and
20 ng Nla8 cRNA. In all experiments, the injection amount ofNla3
and rb2 cRNA washeld at 50 ng. Data are means  SEM of at least
three independent experiments (different batches of oocytes).
Table S1. Kd and Bmax values of imidacloprid binding to high-
and low-afﬁnity binding sites in the 14th (G14) and 16th (G16)
generations of the imidacloprid selected strain of N. lugens.
Table S2. The sequences for qRT-PCR primers.
© 2015 International Society for Neurochemistry, J. Neurochem. (2015) 135, 686--694
692 Y. Zhang et al.
References
Barnes S. (1946) The inﬂuence of certain biological factors on the
resistance of bed-bugs (Cimex lectularius, L.) to DDT. Bull.
Entomol. Res. 36, 419–422.
Bass C., Puinean A. M., Andrews M. et al. (2011a) Mutation of a
nicotinic acetylcholine receptor beta subunit is associated with
resistance to neonicotinoid insecticides in the aphid Myzus
persicae. BMC Neurosci. 12.
Bass C., Carvalho R., Oliphant L., Puinean A., Field L., Nauen R.,
Williamson M., Moores G. and Gorman K. (2011b)
Overexpression of a cytochrome P450 monooxygenase,
CYP6ER1, is associated with resistance to imidacloprid in the
brown planthopper, Nilaparvata lugens. Insect Mol. Biol. 20, 763–
773.
Bradford M. M. (1976) A rapid and sensitive method for the quantitation
of microgram quantities of protein utilizing the principle of protein-
dye binding. Anal. Biochem. 32, 248–254.
Devonshire A. L. (1991) Role of esterases in resistance of insects to
insecticides. Biochem. Soc. Trans. 19, 755–759.
Ding Z., Wen Y., Yang B., Zhang Y., Liu S., Liu Z. and Han Z. (2013)
Biochemical mechanisms of imidacloprid resistance in Nilaparvata
lugens: over-expression of cytochrome P450 CYP6AY1. Insect
Biochem. Mol. Biol. 43, 1021–1027.
Edi C. V., Djogbenou L., Jenkins A. M. et al. (2014) CYP6 P450
enzymes and ACE-1 duplication produce extreme and multiple
insecticide resistance in the malaria mosquito Anopheles gambiae.
PLoS Genet. 10, e1004236.
Enayati A. A., Ranson H. and Hemingway J. (2005) Insect glutathione
transferases and insecticide resistance. Insect Mol. Biol. 14, 3–8.
Ffrench-Constant R. H., Rocheleau T. A., Steichen J. C. and Chalmers
A. E. (1993) A point mutation in a Drosophila GABA receptor
confers insecticide resistance. Nature 363, 449–451.
Ficklin M. B., Zhao S. L. and Feng G. P. (2005) Ubiquilin-1 regulates
nicotine-induced up-regulation of neuronal nicotinic acetylcholine
receptors. J. Biol. Chem. 280, 34088–34095.
Gao J. R. and Zhu K. Y. (2002) Increased expression of an
acetylcholinesterase gene may confer organophosphate resistance
in the greenbug, Schizaphis graminum (Homoptera: Aphididae).
Pestic. Biochem. Physiol. 73, 164–173.
Garrood W. T., Zimmer C. T., Gorman K. J., Nauen R., Bass C. and
Davies T. G. E. (2015) Field-evolved resistance to imidacloprid
and ethiprole in populations of brown planthopper Nilaparvata
lugens collected from across South and East Asia. Pest Manag.
Sci.
Hsu J. C., Wu W. J., Haymer D. S., Liao H. Y. and Feng H. T. (2008)
Alterations of the acetylcholinesterase enzyme in the oriental fruit
ﬂy Bactrocera dorsalis are correlated with resistance to the
organophosphate insecticide fenitrothion. Insect Biochem. Mol.
Biol. 38, 146–154.
Jeanclos E. M., Lin L., Treuil M. W., Rao J., Decoster M. A. and Anand
R. (2001) The chaperone protein 14-3-3g interacts with the
nicotinic acetylcholine receptor a4 subunit - Evidence for a
dynamic role in subunit stabilization. J. Biol. Chem. 276, 28281–
28290.
Jones A. K., Buckingham S. D. and Sattelle D. B. (2010) Proteins
interacting with nicotinic acetylcholine receptors: expanding
functional and therapeutic horizons. Trends Pharmacol. Sci. 31,
455–462.
Li X., Schuler M. A. and Berenbaum M. R. (2007) Molecular
mechanisms of metabolic resistance to synthetic and natural
xenobiotics. Annu. Rev. Entomol. 52, 231–253.
Li J., Shao Y., Ding Z., Bao H., Liu Z., Han Z. and Millar N. S. (2010)
Native subunit composition of two insect nicotinic receptor
subtypes with differing afﬁnities for the insecticide imidacloprid.
Insect Biochem. Mol. Biol. 40, 17–22.
Lind R. J., Clough M. S., Reynolds S. E. and Earley F. G. P. (1998) [3H]
Imidacloprid labels high- and low-afﬁnity nicotinic acetylcholine
receptor-like binding sites in the aphid Myzus persicae (Hemiptera:
Aphididae). Pestic. Biochem. Physiol. 62, 3–14.
Liu S., Ding Z., Zhang C., Yang B. and Liu Z. (2010) Gene knockdown
by intro-thoracic injection of double-stranded RNA in the brown
planthopper, Nilaparvata lugens. Insect Biochem. Mol. Biol. 40,
666–671.
Liu Z., Williamson M. S., Lansdell S. J., Denholm I., Han Z. and Millar
N. S. (2005) A nicotinic acetylcholine receptor mutation conferring
target-site resistance to imidacloprid in Nilaparvata lugens (brown
planthopper). Proc. Natl Acad. Sci. USA 102, 8420–8425.
Liu Z., Williamson M. S., Lansdell S. J., Han Z., Denholm I. and Millar
N. S. (2006) A nicotinic acetylcholine receptor mutation (Y151S)
causes reduced agonist potency to a range of neonicotinoid
insecticides. J. Neurochem. 99, 1273–1281.
Maier T., Guell M. and Serrano L. (2009) Correlation of mRNA and
protein in complex biological samples. FEBS Lett. 583, 3966–3973.
Markussen M. D. K. and Kristensen M. (2010) Low expression of
nicotinic acetylcholine receptor subunit Mda2 in neonicotinoid-
resistant strains of Musca domestica L. Pest Manag. Sci. 66, 1257–
1262.
Martinez-Torres D., Chandre F., Williamson M. S., Darriet F., Berge J.
B., Devonshire A. L., Guillet P., Pasteur N. and Pauron D. (1998)
Molecular characterization of pyrethroid knockdown resistance
(kdr) in the major malaria vector Anopheles gambiae S.S. Insect
Mol. Biol. 7, 179–184.
Millar N. S. (2009) A review of experimental techniques used for the
heterologous expression of nicotinic acetylcholine receptors.
Biochem. Pharmacol. 78, 766–776.
Millar N. S. and Denholm I. (2007) Nicotinic acetylcholine receptors:
targets for commercially important insecticides. Invertebr.
Neurosci. 7, 53–66.
Mutero A., Pralavorio M., Bride J. M. and Fournier D. (1994)
Resistance-associated point mutations in insecticide-insensitive
acetylcholinesterase. Proc. Natl Acad. Sci. USA 91, 5922–5926.
Nelson M. E., Kuryatov A., Choi C. H., Zhou Y. and Lindstrom J.
(2003) Alternate stoichiometries of a4b2 nicotinic acetylcholine
receptors. Mol. Pharmacol. 63, 332–341.
Noda H., Kawai S., Koizumi Y., Matsui K., Zhang Q., Furukawa S.,
Shimomura M. and Mita K. (2008) Annotated ESTs from
various tissues of the brown planthopper Nilaparvata lugens: a
genomic resource for studying agricultural pests. BMC Genom.
9, 117.
Pan Y. O., Shang Q. L., Fang K., Zhang J. and Xi J. H. (2010) Down-
regulated transcriptional level of Ace1 combined with mutations in
Ace1 and Ace2 of Aphis gossypii are related with omethoate
resistance. Chem. Biol. Interact. 188, 553–557.
Rezvani K., Teng Y., Pan Y., Dani J. A., Lindstrom J., Garcia Gras E.
A., Mcintosh J. M. and De Biasi M. (2009) UBXD4, a UBX-
containing protein, regulates the cell surface number and stability
of a3-containing nicotinic acetylcholine receptors. J. Neurosci. 29,
6883–6896.
Sattelle D. B. (1980) Acetylcholine Receptors of Insects, in Adv. Insect
Physiol., (Treherne J. E., Berridge M. J. and Wigglesworth V. B.,
eds), Vol. 15, pp. 215–315. Academic Press, London.
Scott J. G. (1999) Cytochromes P450 and insecticide resistance. Insect
Biochem. Mol. Biol. 29, 757–777.
Shang Q. L., Pan Y., Fang K., Xi J. H., Wong A., Brennan J. A. and Cao
C. W. (2014) Extensive Ace2 duplication and multiple mutations
on Ace1 and Ace2 are related with high level of organophosphates
resistance in Aphis gossypii. Environ. Toxicol. 29, 526–533.
© 2015 International Society for Neurochemistry, J. Neurochem. (2015) 135, 686--694
Reduction in target leads to insecticide resistance 693
Shen G. M., Wang X. N., Dou W. and Wang J. J. (2012) Biochemical
and molecular characterisation of acetylcholinesterase in four ﬁeld
populations of Bactrocera dorsalis (Hendel) (Diptera: Tephritidae).
Pest Manag. Sci. 68, 1553–1563.
Taillebois E., Beloula A., Quinchard S., Jaubert-Possamai S., Daguin
A., Servent D., Tagu D., Thany S. H. and Tricoire-Leignel H.
(2014) Neonicotinoid binding, toxicity and expression of nicotinic
acetylcholine receptor subunits in the aphid Acyrthosiphon pisum.
PLoS ONE 9, e96669, doi:10.1371/journal.pone.0096669.
Tang J., Li J., Shao Y., Yang B. and Liu Z. (2010) Fipronil resistance in
the whitebacked planthopper (Sogatella furcifera): possible
resistance mechanisms and cross-resistance. Pest Manag. Sci. 66,
121–125.
Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De
Paepe A. and Speleman F. (2002) Accurate normalization of real-
time quantitative RT-PCR data by geometric averaging of multiple
internal control genes. Genome Biol. 3, Research0034.
Wang Y., Chen J., Zhu Y. C., Ma C., Huang Y. and Shen J. (2008)
Susceptibility to neonicotinoids and risk of resistance development
in the brown planthopper, Nilaparvata lugens (Stal) (Homoptera:
Delphacidae). Pest Manag. Sci. 64, 1278–1284.
Weetman D., Mitchell S. N., Wilding C. S. et al. (2015) Contemporary
evolution of resistance at the major insecticide target site gene
Ace-1 by mutation and copy number variation in the malaria
mosquito Anopheles gambiae. Mol. Ecol. 24, 2656–2672.
Williamson M. S., Martineztorres D., Hick C. A. and Devonshire A. L.
(1996) Identiﬁcation of mutations in the houseﬂy para-type sodium
channel gene associated with knockdown resistance (kdr) to
pyrethroid insecticides. Mol. Gen. Genet. 252, 51–60.
Williamson S. M., Robertson A. P., Brown L., Williams T., Woods D. J.,
Martin R. J., Sattelle D. B. and Wolstenholme A. J. (2009) The
nicotinic acetylcholine receptors of the parasitic nematode Ascaris
suum: formation of two distinct drug targets by varying the relative
expression levels of two subunits. PLoS Pathog. 5, e1000517.
Yan H. H., Xue C. B., Li G. Y., Zhao X. L., Che X. Z. and Wang L. L.
(2014) Flubendiamide resistance and Bi-PASA detection of
ryanodine receptor G4946E mutation in the diamondback moth
(Plutella xylostella L.). Pestic. Biochem. Physiol. 115, 73–77.
Yixi Z., Liu Z., Han Z., Song F., Yao X., Shao Y., Li J. and Millar N. S.
(2009) Functional co-expression of two insect nicotinic receptor
subunits (Nla3 and Nla8) reveals the effects of a resistance-
associated mutation (Nla3Y151S) on neonicotinoid insecticides. J.
Neurochem. 110, 1855–1862.
Zwart R. and Vijverberg H. P. M. (1998) Four pharmacologically distinct
subtypes of a4b2 nicotinic acetylcholine receptor expressed in
Xenopus laevis oocytes. Mol. Pharmacol. 54, 1124–1131.
© 2015 International Society for Neurochemistry, J. Neurochem. (2015) 135, 686--694
694 Y. Zhang et al.
